Chien-Lung Hsu | Healthcare | Best Researcher Award

Posted on by Academic achievements

Prof. Chien-Lung Hsu | Healthcare | Best Researcher Award

Professor at Chang-Gung University (CGU), Taiwan.

Dr. Chien-Lung Hsu is a distinguished Professor in the Department of Information Management at Chang Gung University (CGU), Taiwan. Additionally, he serves as a Professor at the Graduate Institute of Business and Management and an Adjunct Professor at both Ming-Chi University of Technology and Chang-Gung Memorial Hospital. He received his Ph.D. in Information Management from National Taiwan University of Science and Technology in 2002. Dr. Hsu is the Director of the Ubiquitous Security and Applications Lab and has contributed significantly to research areas such as cryptography, information security, mobile commerce, and IoT. His notable achievements include leading international projects, such as Taiwan-Japan collaborative research on lightweight cryptosystems for IoT-based eHealth. With over 100 international journal publications and several best paper awards, Dr. Hsu is highly regarded in his field. He also holds multiple certifications in cybersecurity, demonstrating expertise as an educator and practitioner in the domain.

Profile Verification

Scopus 

Education

Dr. Chien-Lung Hsu holds a Ph.D. in Information Management from the National Taiwan University of Science and Technology, which he earned in 2002. He also completed an M.S. in Information Management at the same institution in 1997 and received his B.S. in Business Administration in 1995. Dr. Hsu’s academic journey uniquely combines the fields of information management and business administration, providing him with a versatile and interdisciplinary foundation. His doctoral research delved into secure information systems, focusing on developing innovative solutions in cryptography and information security. This work laid the groundwork for his prolific academic and professional career, where he has contributed significantly to advancements in cybersecurity, mobile commerce, digital forensics, and big data technologies. In addition to his studies, Dr. Hsu has mentored numerous students and collaborated on transformative projects that integrate business acumen with cutting-edge information management systems. His educational background continues to influence his impactful research and teaching endeavors.

Experience

Dr. Hsu’s career spans academia, research, and industry collaboration. At Chang Gung University, he has held pivotal roles, including directing advanced programs in IoT, big data, and medical applications. Between 2012 and 2013, he served as a Visiting Professor in the Department of Electrical Engineering and Computer Science at the University of Central Florida (UCF). Dr. Hsu’s leadership includes being a Director of the Chinese Cryptology (CCISA) and Chair of its Membership and Education Promotion Committees. His professional activities also encompass organizing international conferences and symposia, such as the International Security Conference (ISC) and Medical Informatics Symposium in Taiwan. He actively collaborates with Taiwan’s Ministry of Science and Technology, leading cutting-edge research projects in information security and healthcare. His multidisciplinary roles reflect his commitment to integrating technological innovation into societal benefits.

Research Interests

Dr. Chien-Lung Hsu’s research encompasses a wide array of domains, each contributing significantly to the advancement of technology and security. His work in cryptography 🔐 and information security 🛡️ ensures robust mechanisms for safeguarding data across platforms. In mobile commerce 📱 and digital forensics 🔍, he explores innovative solutions to enhance transaction security and forensic investigation methodologies. Dr. Hsu’s focus on healthcare informatics 🏥 integrates secure and efficient data systems to support medical applications. Additionally, his expertise in big data analytics 📊 and the Internet of Things (IoT) 🌐 drives the development of scalable, intelligent, and secure networks for industrial and healthcare use. One of his hallmark contributions is the Taiwan-Japan joint project on lightweight cryptosystems for IoT-based eHealth environments, which emphasizes data integrity and scalability. By adopting an interdisciplinary approach, Dr. Hsu addresses pressing cybersecurity challenges, fostering safer and more reliable digital ecosystems.

Awards and Honors

Dr. Chien-Lung Hsu has received numerous accolades throughout his distinguished career, highlighting his expertise and contributions to the fields of information security and healthcare research. He was honored with the Distinguished Research Award from the Taiwan Ministry of Science and Technology, a testament to his impactful academic and scientific endeavors. Dr. Hsu has also earned multiple Best Paper Awards, including those from eCASE 2010, CISC 2010, JCMIT 2015, and MMHS 2015, showcasing his ability to produce cutting-edge research in highly competitive fields. His dedication and innovation have been further recognized with Research Rewards from Chang Gung University and Chang Gung Memorial Hospital. As a senior member of professional organizations and a certified cybersecurity expert, Dr. Hsu continues to play a pivotal role in advancing Taiwan’s technological landscape. His contributions to academia and industry remain influential and widely celebrated.

Publications

A Hierarchical Blockchain System for Social Economy Services

Authors: Chin, Y.-C.; Hsu, C.-L.; Lin, T.-W.; Tsai, K.-Y.

Year: 2024

Citations: 0

Design and Evaluation of Device Authentication and Secure Communication System with PQC for AIoT Environments

Authors: Chen, Y.-J.; Hsu, C.-L.; Lin, T.-W.; Lee, J.-S.

Year: 2024

Citations: 0

Technological Empowerment for Aging Workforce in Elderly Care Programs: Service Model Design and Development of an Elderly Care Shared Service Platform

Authors: Tsai, T.-H.; Lo, H.-Y.; Wu, S.-L.; Chen, Y.-P.; Hsu, C.-L.

Year: 2024

Citations: 0

ID-Based Deniable Authentication Protocol with Key Agreement and Time-Bound Properties for 6G-Based WBAN Healthcare Environments

Authors: Hsu, C.-L.; Nguyen, A.-T.; Cheng, G.-L.

Year: 2023

Citations: 0

Developing the “Healthcare CEO App” for Patients with Type 1 Diabetes Transitioning from Adolescence to Young Adulthood: A Mixed-Methods Study

Authors: Chiang, Y.-T.; Chang, C.-W.; Yu, H.-Y.; An, C.; Moons, P.

Year: 2023

Citations: 2

BONE+: An AI-Driven Chatbot Platform for Promoting Behavior Change in Bone Health and Osteoporosis Prevention

Authors: Tsai, T.-H.; Hsieh, Y.-S.; Ho, C.-S.; Pei, Y.-C.; Hsu, C.-L.

Year: 2023

Citations: 0

Privacy-Preserved Hierarchical Authentication and Key Agreement for AI-Enabled Telemedicine Systems

Authors: Lin, T.-W.; Hsu, C.-L.

Year: 2023

Citations: 2

A Hybrid Blockchain-Based Log Management Scheme with Nonrepudiation for Smart Grids

Authors: Le, T.-V.; Hsu, C.-L.; Chen, W.-X.

Year: 2022

Citations: 18

Evaluating Digital Divide Based on Big Wireless Logs: A Case Study among Remote Tribes in Taiwan

Authors: Chen, S.-H.; Li, H.-C.; Liaw, Y.-C.; Le, T.-V.; Luo, W.-L.

Year: 2022

Citations: 2

A Novel Three-Factor Authentication Protocol for Multiple Service Providers in 6G-Aided Intelligent Healthcare Systems

Authors: Le, T.-V.; Lu, C.-F.; Hsu, C.-L.; Chou, Y.-F.; Wei, W.-C.

Year: 2022

Citations: 24

Conclusion

Dr. C.L. Hsu is an exceptional candidate for the Best Researcher Award due to his groundbreaking interdisciplinary research, strong leadership roles, and extensive academic contributions. His work on cryptography and information security, particularly its applications in healthcare and IoT, has significant societal and technological implications. While there is potential for greater emphasis on specific contributions and broader community engagement, his current achievements make him a compelling nominee. Recognizing Dr. Hsu would not only honor his accomplishments but also inspire further innovation in critical research areas.

 

Martin NICOL | Medical | Best Paper Award

Posted on by Academic achievements

Dr. Martin NICOL | Medical | Best Paper Award

Doctor at Cardiology department, Lariboisiere Saint Louis University of Paris, France

Dr. Martin Nicol is a distinguished French cardiologist with a specialization in cardio-oncology, cardiac imaging, and cardiovascular diseases. With over a decade of experience in both clinical and academic roles, he has made significant contributions to cardiology through his research, teaching, and clinical expertise. His work has garnered recognition at international conferences, and he continues to lead in the development of specialized cardiac care.

Profile:

SCOPUS

Education:

Dr. Nicol’s educational journey is rooted in some of France’s most prestigious institutions. He completed his medical degree from Université Paris 7 in 2018, where he also earned a Doctorate in Medicine. His postdoctoral training includes a DES in cardiology and vascular diseases from Université Paris 6. Dr. Nicol further specialized by obtaining several diplomas, including a DIU in cardio-oncology and echocardiography. His extensive academic background provided a solid foundation for his later research and clinical endeavors.

Experience:

Dr. Nicol’s professional experience spans across leading hospitals in Paris, where he served as an intern and later as a fellow in multimodal cardiac imaging at the Centre Cardiologique du Nord. He gained valuable experience in echocardiography, MRI, and cardiac scanning. From 2019 to 2021, he was the Chief of Clinic in the cardiology department at Lariboisière Hospital, where he developed specialized consultations in cardio-oncology. In 2022, he transitioned to private practice, joining the Maison Médicale de Mareil Marly and Ambroise Paré Hospital. Dr. Nicol also continues his work at Saint Louis Hospital, specializing in the treatment of amyloidosis.

Research Interest:

Dr. Nicol’s research is deeply centered on cardiovascular diseases, specifically focusing on cardiac amyloidosis, cardio-oncology, and cardiac imaging. His doctoral thesis on myocardial stiffness in heart failure highlighted his commitment to advancing diagnostic and treatment methods for complex cardiovascular conditions. He has collaborated with international research groups to further explore these areas, particularly in the integration of imaging modalities and their prognostic values.

Awards:

Dr. Nicol has received numerous accolades for his contributions to cardiology research. Notable among these is the Young Investigator Award at the Global Cardio-Oncology Summit in 2018 for his diagnostic score of cardiac involvement in AL amyloidosis. He also won several awards for his work on the cardiotoxicity induced by doxorubicin and trastuzumab, including the Best Oral Communication Award at GRRC 2018 and Best Poster Award at JFIC 2018.

Publications:

Dr. Nicol has published extensively in reputable cardiology journals. His work spans topics from subclinical left ventricular dysfunction during chemotherapy to the prognosis of cardiac amyloidosis. Some of his key publications include:

Nicol M, Deblaise J, Choussat R, Dubourg O, Mansencal N. “Side effects of ticagrelor: sinus node dysfunction with ventricular pause.” Int J Cardiol, 2015. Cited by 56 articles.

Nicol M, Baudet M, Cohen Solal A. “Subclinical left ventricular dysfunction during chemotherapy.” Card Fail Rev, 2019. Cited by 45 articles.

Nicol M, Cescau A, Baudet M, Harel S, Royer B. “Prognostic value of 123-I MIBG in AL amyloidosis.” Circ Cardiovasc Imaging, 2019. Cited by 38 articles.

Nicol M, Deney A, Lairez O, Vergaro G, Emdin M. “Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis.” Eur J Heart Fail, 2021. Cited by 29 articles.

Nicol M, Sadoune M, Azibani F. “Doxorubicin and trastuzumab induced cardiotoxicity in mice is not prevented by metoprolol.” ESC Heart Fail, 2021. Cited by 22 articles.

Nicol M, Siguret V, Vergaro G. “Thrombo-embolism and bleeding in patients with amyloidosis: A review.” ESC Heart Fail, 2022. Cited by 16 articles.

Nicol M, Hubert A, Coisne A. “Reproducibility of the 2016 American Society of Echocardiography-Algorithm for Estimation of Left Ventricular Filling Pattern.” Ultrasound Med Biol, 2022. Cited by 12 articles.

Nicol M, Vergaro G, Damy T. “Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis.” Front Cardiovasc Med, 2023. Cited by 10 articles.

Conclusion

Dr. Martin Nicol’s research contributions, particularly in the field of cardio-oncology and cardiac amyloidosis, make him a strong candidate for the Best Research Paper Award. His impressive record of publications, awards, and innovative research in multimodal cardiac imaging align well with the award’s criteria. Expanding his clinical trial work and focusing on mentorship could further enhance his qualifications, but his current profile already demonstrates a remarkable level of expertise and impact.

Selvia Hanna | Clinical Pharmacy | Best Researcher Award

Posted on by Academic achievements

Dr. Selvia Hanna | Clinical Pharmacy | Best Researcher Award

Senior Clinical Pharmacist | Beni-Suef University Hospital | Egypt

👩‍🔬 Short Bio:

Selvia Maher Farag Hanna is a dedicated Senior Clinical Pharmacist and Member of the Clinical Research Center at Beni-Suef University Hospital, specializing in Cardiology. With 12 years of experience, she excels in medication therapy management and improving patient outcomes through interdisciplinary collaboration.

Profile:

SCOPUS

📚 Education:

Selvia completed her Doctor of Philosophy in Pharmaceutical Sciences (Clinical Pharmacy) at Beni-Suef University in July 2024. She holds a Master’s degree in Pharmaceutical Sciences (Clinical Pharmacy) and a Bachelor’s degree in Pharmaceutical Sciences, both from Beni-Suef University.

💼 Experience:

Since July 2012, Selvia has served as a Clinical Pharmacist at Beni-Suef University Hospital, focusing on medication management in the Cardiology care unit. Previously, she worked at El-Masrya Pharmacy, gaining experience in medication counseling and drug utilization review.

🔬 Research Interest:

Selvia’s research interests revolve around Cardiology, specifically hypertension management, drug interactions, and patient-centric care strategies to enhance treatment efficacy and safety.

🏆 Award:

Recipient of the Distinguished Scientist Award for her contributions to Clinical Pharmacy and Cardiology research.

📄 Publications:

  1. Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure
    Published in High Blood Pressure & Cardiovascular Prevention, November 2018.
    View Publication
    Cited 11 times.
  2. Effect of Fixed-dose Combination Amlodipine/Valsartan in Comparison to Two Drug Combination Nebivolol/Valsartan on 24-Hour Ambulatory Blood Pressure
    Published in Current Hypertension Reviews, May 2023.
    View Publication
  3. Target Blood Pressure and Combination Therapy: Focus on Angiotensin Receptor Blockers Combination with Either Calcium Channel Blockers or Beta Blockers
    Published in Current Hypertension Reviews, September 2022.
  4. Safety and efficacy of candesartan versus valsartan combined with amlodipine on peripheral and central blood pressure
    Published in Hipertension y Riesgo Vascular, January–March 2024.